Essential and timely resource for funders, policy makers, researchers and academics involved in research on pharmaceutical policy or involved in the teaching of pharmacy or medicine.

Autorentext

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has an in-depth understanding of global health, pharmacy systems and pharmaceutical policy and has worked in Malaysia, New Zealand, Pakistan and the UK.

Klappentext

The only text available today which provides an up to date account of international pharmaceutical policy research. Analyses the most relevant areas that may impact on the quality use of medicines and ultimately the health of populations. Fills a significant gap in the literature by offering a comprehensive analysis of pharmaceutical policy from a global point of view. Essential and timely resource for funders, policy makers, researchers and academics involved in research on pharmaceutical policy or involved in the teaching of pharmacy or medicine.

Inhalt
1 Medicines Safety in the Gloablized Context.- 2 Managing the Pharmaceutical Supply Chain To Sustainability and Beyond.- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy.- 4 Global Access to Cancer Medicines.- 5 Medicines Pricing: Limitations of Existing Policies and New Models.- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019.- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components.- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan).- 9 Access and Use of Medicines in Ukraine.- 10 Public Participation in Access to Medicines.- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China.- 12 Access to Vaccines and Immunization Programme.- 13. Global Antibiotics Use and Resistance.- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider.